Free Cash Flow

Orphazyme A/S (ORPH)

$ 21.15
11.1 (+110.45%)

Free Cash Flow

Year
A/P
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue -----------
Revenue (%)
Operating Cash Flow -----------
Operating Cash Flow (%)
Capital Expenditure -----------
Capital Expenditure (%)
Free Cash Flow -----------

FCF Unlevered from cash flow statement